Congress is considering a bill that would lower prescription drug prices and it could have a big impact on Indianapolis-based Eli Lilly and Co. We get insight from Dave Ricks.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}